Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) traded up 4.9% during trading on Friday after Bank of America raised their price target on the stock from $24.00 to $26.00. Bank of America currently has a buy rating on the stock. Stevanato Group traded as high as €24.90 ($26.21) and last traded at €23.57 ($24.81). 371,527 shares changed hands during trading, a decline of 26% from the average session volume of 499,755 shares. The stock had previously closed at €22.47 ($23.65).
A number of other analysts have also recently commented on the stock. Morgan Stanley restated an “equal weight” rating and set a $23.00 price target (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Wolfe Research began coverage on Stevanato Group in a research report on Friday. They set an “outperform” rating and a $28.00 target price on the stock. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of €28.60 ($30.11).
Read Our Latest Research Report on Stevanato Group
Institutional Trading of Stevanato Group
Stevanato Group Trading Up 3.7 %
The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The stock’s 50 day simple moving average is €19.67 and its 200 day simple moving average is €19.67. The firm has a market cap of $6.89 billion, a PE ratio of 49.60, a PEG ratio of 9.79 and a beta of 0.59.
Stevanato Group (NYSE:STVN – Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.16 EPS. On average, sell-side analysts forecast that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.
Stevanato Group Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Recommended Stories
- Five stocks we like better than Stevanato Group
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What Are the U.K. Market Holidays? How to Invest and Trade
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Industrial Products Stocks Investing
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.